CEBPB and neoplasm: In a test of the role of CEBPB (C/EBPβ) in PCa cell autophagy compliant with bortezomib treatment, the authors detected a reduction in the tumor growth rate of PC3 cells expressing shCEBPB, and reducing C/EBPβ enhanced sensitivity to bortezomib treatment in vivo experiments [54].